108 related articles for article (PubMed ID: 29392812)
1. Mechanism-Based Inhibitor of DNA Cytosine-5 Methyltransferase by a S
Sato K; Kunitomo Y; Kasai Y; Utsumi S; Suetake I; Tajima S; Ichikawa S; Matsuda A
Chembiochem; 2018 Apr; 19(8):865-872. PubMed ID: 29392812
[TBL] [Abstract][Full Text] [Related]
2. Improvement of S
Kasai Y; Sato K; Utsumi S; Ichikawa S
Chembiochem; 2018 Sep; 19(17):1866-1872. PubMed ID: 29900657
[TBL] [Abstract][Full Text] [Related]
3. An oligodeoxyribonucleotide containing 5-formyl-2'-deoxycytidine (fC) at the CpG site forms a covalent complex with DNA cytosine-5 methyltransferases (DNMTs).
Sato K; Kawamoto K; Shimamura S; Ichikawa S; Matsuda A
Bioorg Med Chem Lett; 2016 Nov; 26(22):5395-5398. PubMed ID: 27780634
[TBL] [Abstract][Full Text] [Related]
4. Insight into the recognition mechanism of DNA cytosine-5 methyltransferases (DNMTs) by incorporation of acyclic 5-fluorocytosine (
Utsumi S; Sato K; Ichikawa S
Bioorg Med Chem Lett; 2018 Jul; 28(12):2189-2194. PubMed ID: 29752184
[TBL] [Abstract][Full Text] [Related]
5. DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site.
van Bemmel DM; Brank AS; Eritja R; Marquez VE; Christman JK
Biochem Pharmacol; 2009 Sep; 78(6):633-41. PubMed ID: 19467223
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of DNA (cytosine C5)-methyltransferases by oligodeoxyribonucleotides containing 5,6-dihydro-5-azacytosine.
Sheikhnejad G; Brank A; Christman JK; Goddard A; Alvarez E; Ford H; Marquez VE; Marasco CJ; Sufrin JR; O'gara M; Cheng X
J Mol Biol; 1999 Feb; 285(5):2021-34. PubMed ID: 9925782
[TBL] [Abstract][Full Text] [Related]
7. Nucleosides and nucleotides. CXIX. Inhibition of DNA-cytosine methylase HhaI by a self-complementary oligonucleotide containing 5-fluorocytosine.
Ono A; Matsuo Y; Matsuda A; Ueda T
Biol Pharm Bull; 1993 Jun; 16(6):529-33. PubMed ID: 8364503
[TBL] [Abstract][Full Text] [Related]
8. Role of protein-protein interactions in allosteric drug design for DNA methyltransferases.
Liang Z; Zhu Y; Liu X; Hu G
Adv Protein Chem Struct Biol; 2020; 121():49-84. PubMed ID: 32312426
[TBL] [Abstract][Full Text] [Related]
9. DNA Methyltransferases in Mammalian Oocytes.
Uysal F; Ozturk S
Results Probl Cell Differ; 2017; 63():211-222. PubMed ID: 28779320
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
[TBL] [Abstract][Full Text] [Related]
11. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer.
Gnyszka A; Jastrzebski Z; Flis S
Anticancer Res; 2013 Aug; 33(8):2989-96. PubMed ID: 23898051
[TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs.
Yu J; Xie T; Wang Z; Wang X; Zeng S; Kang Y; Hou T
Drug Discov Today; 2019 Dec; 24(12):2323-2331. PubMed ID: 31494187
[TBL] [Abstract][Full Text] [Related]
13. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.
Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: implications for the mechanism of inhibition of DNMTs.
Yoo J; Choi S; Medina-Franco JL
PLoS One; 2013; 8(4):e62152. PubMed ID: 23637988
[TBL] [Abstract][Full Text] [Related]
15. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
Zhou Z; Li HQ; Liu F
Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
[TBL] [Abstract][Full Text] [Related]
16. Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma.
Hervouet E; Peixoto P; Delage-Mourroux R; Boyer-Guittaut M; Cartron PF
Clin Epigenetics; 2018; 10():17. PubMed ID: 29449903
[TBL] [Abstract][Full Text] [Related]
17. Impact of cytosine 5-halogens on the interaction of DNA with restriction endonucleases and methyltransferase.
Valinluck V; Wu W; Liu P; Neidigh JW; Sowers LC
Chem Res Toxicol; 2006 Apr; 19(4):556-62. PubMed ID: 16608167
[TBL] [Abstract][Full Text] [Related]
18. Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors.
Rondelet G; Fleury L; Faux C; Masson V; Dubois J; Arimondo PB; Willems L; Wouters J
Future Med Chem; 2017 Sep; 9(13):1465-1481. PubMed ID: 28795598
[TBL] [Abstract][Full Text] [Related]
19. Sequence-specific and mechanism-based crosslinking of Dcm DNA cytosine-C5 methyltransferase of E. coli K-12 to synthetic oligonucleotides containing 5-fluoro-2'-deoxycytidine.
Hanck T; Schmidt S; Fritz HJ
Nucleic Acids Res; 1993 Jan; 21(2):303-9. PubMed ID: 8441638
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2-Amino-4-Fluoropyridine-C-Nucleoside Phosphoramidite for Incorporation into Oligonucleotides.
Sato K; Matsuda A
Curr Protoc Nucleic Acid Chem; 2019 Jun; 77(1):e77. PubMed ID: 30747492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
